Baxter Launches Zosyn Premix in US | MarketScreener

Supports Baxter’s ongoing efforts to expand its anti-infective portfolio to increase access to essential medications and advance patient care



Frozen premix formulation helps support patient... | April 4, 2023

Related Keywords

Alok Sonig ,Hemophagocytic Lymphohistiocytosis ,Baxter Pharmaceuticals ,Twitter ,Facebook ,Baxter International Inc ,Linkedin ,Baxter International ,Important Risk Information ,Prescribing Information ,Important Risk ,Adverse Reactions ,Cutaneous Adverse Reactions ,Nervous System Adverse Reactions ,Critically Ill Patients ,Baxter International Inc Stock Exchange ,News ,Information ,Press Release ,Supports ,Ngoing ,Efforts ,O ,Xpand ,Its ,Portfolio ,Increase ,Access ,Essential ,Medications ,End ,Advance ,Patient ,Remix ,Formulation ,Elps ,Upport Bax Us0718131099 ,